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Epigenetics, society, and bio-
objects
The molecular account of the environmental that epige-
netics offers bestow it with paramount importance for bio-
medical perspective of health and disease and for social 
sciences perspective on human interactions and well-be-
ing. It offers new prospects for interventions to shape the 
health of both individuals and populations, and invokes 
its own ethical, legal, and social implications. We here pro-
pose treatment of the relation between epigenetics and 
society through the framework of bio-objectification. Af-
ter discussing how epigenetic information becomes part 
of particular bio-identification and bio-objectification pro-
cesses, we then propose the bio-objectification framework 
as a fruitful conceptual framework for the analysis of dy-
namic research and responsive regulatory landscape of 
this biotechnology.
“What counts more: nature or nurture, the biological or the 
social” has long been occupying minds of various people, 
from philosophers, to social and natural scientists, to poli-
ticians and physicians, as well as of common citizens. Al-
though much has been said on this topic from an “interac-
tionist” point of view (both aspects, biological/nature and 
social/nurture, are important), the “divide” survived into 
contemporary days with “wars” being fought on whether 
it is the DNA or the environment that make us who we are. 
In this sense, the cover of the Time Magazine “Why your 
DNA isn’t your destiny” (1) epitomizes “the new interac-
tionist” paradigm brought about by rapid developments 
in the field of epigenetics. With reference to what is on or 
above the genome (epi- in Greek), “epigenetics collective-
ly describes changes in the regulation of gene expres-
sion that can be passed on to a cell’s progeny but are 
not due to changes to the nucleotide sequence of 
the gene” (2). These changes, depicted through epigenet-
ic marks, “determine which genes are expressed by which 
cell type, and when” (2) and are transducers of the envi-
ronments in which genes prevail. And as technological de-
velopments make possible the study of more and more 
complex interactions of genes and their environments, 
the “gene context” (in genetic science, considered as the 
cellular context of the genes) gets extended beyond the 
cellular level to tie variations in gene expression between 
individuals with social variables like socio-economic status 
(3,4) and industrialization- and urbanization-produced life 
styles (5). Such molecular account of the social grants epi-
genetics paramount importance. It influences, on the one 
hand, biomedical perspective of health and disease, and, 
on the other hand, social sciences perspective on human 
interactions and well-being. Molecular visibility (6) of such 
wide spectrum of effects, from environmental pollution to 
parental care, to individual lifestyles or socio-economic sta-
tus, proposed by epigenetics, together with the plasticity 
of epigenetic marks, offers new prospects for interventions 
to shape the health of both individuals and populations.
One proposal as to how epigenetics promises to deliver 
these prospects relies on causality: epigenetics will finally 
allow to causally link environmental and social exposures 
to bodily and health outcomes. Once the cascade of causal 
events that leads to poor health outcomes becomes dis-
sected, it will be possible to interfere with these processes 
to: 1) provide better treatment as well as diagnostic and 
prognostic tools, and 2) develop effective preventive strat-
egies. This “causal” reading of epigenetics bears great im-
plications for responsibility for health. In cases of undesir-
able health outcomes and allocation of limited health care 
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resources, it could tip the balance between the individual 
responsibility for “poor health-related behaviour” and so-
ciety and community responsibility for providing enough 
opportunities for “good health-related behaviour” (7). Tip-
ping the balance between individual and collective re-
sponsibility inevitably invites questions of what counts as 
good and poor health-related behavior and how to disen-
tangle multitude of factors. For example, when the same 
individual that does not smoke but practices very bad eat-
ing habits (which can indeed reflect either their personal 
choice to eat unhealthy, but might be influenced by the 
lower economic status or work related conditions), which 
of all these factors should be considered in deciding the 
factor that caused undesirable health outcome? The ques-
tion of whose responsibility the lived life represents is then 
closely tied to questions of how to establish risk catego-
ries and how to stratify people across these categories ac-
cording to their health-related behavior (8). And if the so-
cial is of major importance to gene expression, how do we 
weight social patterns of behavior or dietary patterns that 
strengthen well-being and community?
The epigenetics promises to deliver the above mentioned 
prospects through digitization: epigenetics is a transformer 
of analogical vastness of the environmental and the social 
into digital, code- and therefore genome-compatible infor-
mation (9). On this perspective, a new layer of complex-
ity is added to the existing debates on bio-data manage-
ment, with one of the leading concerns being related to 
identifiability of patients and research participants in cases 
of privacy breaches into databases (10,11). As potentially 
sensitive information about individuals’ private lifestyles 
becomes digitized in epigenomic data sets, it is digitally 
linked to their unique and therefore identifiable genom-
ic data, some of which are stored in publically accessible 
databases. After listing just few of the most prominent 
ethical, legal and social concerns (12,13), we here attempt 
treatment of the relation between epigenetics and society 
through the framework of bio-objectification. In discuss-
ing how biological material (biomaterial) and information 
obtained from tinkering with that material (bio-informa-
tion) become part of particular bio-identification (analyti-
cal process of asking what new relations novel bio-objects 
generates and/or upset, and how they are/could be gov-
erned) and potentially bio-objectification processes (analy-
sis of the ways in which novel bio-objects are created and 
‘natural’ boundaries they disturb), we propose the bio-ob-
jectification framework as a fruitful conceptual framework 
for the analysis of dynamic research and responsive regula-
tory landscape of biotechnology.
The concepts of bio-objects, bio-objectification and bio-
identification have been launched and elaborated within 
the frame of the COST Action IS 1001 as new tools for anal-
ysis of present bio-technology products (novel biological 
materials and forms of life), their production processes, and 
their social, economic and cultural implications and conse-
quences (14). Bio-objects as entities move between institu-
tional, regulatory and legal boarders of research, medicine, 
food, agriculture and industry (15,16). There are epigenetic 
research outputs whose potential bio-objectification value 
has been anticipated by their technological predecessor: 1) 
epigenetically reprogrammed cell types (induced pluripo-
tent stem cells, iPSCs, and their differentiated derivatives), 
which can be used for both replacement therapy and drug 
discovery process (17), and 2) predictive epigenetic pro-
files, which will require (due to above mentioned complex 
nature of epigenetic marks - namely plasticity in relation 
to environmentally and socially induced changes) pro-
spective epigenome sampling and deposition of source 
tissues and cells in biorepositories. Since both of these 
outputs, iPSCs and predictive epigenetic profiles, have dis-
tinct characteristics, compared to their technological pre-
decessors, they do require a new cycle of bio-identification 
process before they can be granted any bio-objectification 
value. However, we believe that the original contribution 
that epigenetics offers to the bio-objectification frame-
work is the possibility to include the environmental con-
text in general, and the social context in particular, in what 
is bio-objectifiable. We thus propose the social context itself 
as target for bio-identification and as potential bio-object. 
Still our claim is not that account of the social put forward 
by epigenetics will and should simply replace all others ac-
counts. Rather, it should be considered as complementary 
to non-molecular accounts as it offers new insights into re-
lations between the social and the biological, visualizing 
how the social becomes molecularly embodied. That be-
ing said, the molecular embodiments of the social are: 1) 
sampled in the form of biological materials (entities); 2) re-
corded and measured in the form of epigenetic informa-
tion (bio-virtual); 3) transformed into digital read-outs (bio-
virtual with potential for bio-objectification), 3) archived in 
the form of both biological materials and digital read-outs, 
and 4) manipulated for research and/or technology-out-
put purposes.
“The social” in epigenetics runs across all dimensions in 
bio-objectification and can indeed be considered as a 
bio-objectifiable itself. Moreover, some of the concerns 
were raised to the inclusion of “the social” in epigenet-
ics. We would like to invite further investigation of 
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epigenetics through bio-objectification framework in trac-
ing and analyzing interrelatedness, transformation and 
movement of its research outputs in general, and of the 
social context in particular. We propose recent discussion 
within the bio-objects network and bio-objectification 
framework on European policy and economy with respect 
to the value of bio-objects and the new bio-economies 
they produce (18,19) as one direction in which this investi-
gation of the social and epigenetics can be furthered.
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